mk-1775 Report issue

Small molecule Experimental
AACT ChEMBL DrugBank MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: CN1CCN(CC1)c2ccc(Nc3ncc4C(=O)N(CC=C)N(c5cccc(n5)C(C)(C)O)c4n3)cc2
  • InChIKey: BKWJAKQVGHWELA-UHFFFAOYSA-N
  • Mol. Mass: 500.61
  • ALogP: 2.89
  • ChEMBL Molecule:
    azd-1775  
More Chemistry

Pharmacology

Alternative names

azd1775 | azd 1775 | azd-1775 | mk1775 | mk 1775 | mk-1775

Organizations (36)

Research & Development (36)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (53)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (53)


 

Astrocytoma (Phase 1)

Bile Duct Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Brenner Tumor (Phase 2)

Carcinoma (Early Phase 1)

Carcinoma, Ovarian Epithelial (Phase 2)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Carcinoma, Verrucous (Phase 2)

Central Nervous System Neoplasms (Phase 1/Phase 2)

Cerebrospinal Fluid (Phase 1)

Colonic Neoplasms (Phase 2)

Colorectal Neoplasms (Phase 2)

Diffuse Intrinsic Pontine Glioma (Phase 1)

Endometrial Neoplasms (Phase 2)

Esophageal Neoplasms (Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Glioblastoma (Phase 1)

Glioma (Phase 2)

Gliosarcoma (Phase 1)

Hamartoma (Phase 2)

Kidney Neoplasms (Phase 2)

Laryngeal Neoplasms (Phase 1)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)

Leukemia, Myeloid, Acute (Phase 2)

Leukemia, Myeloid, Chronic-Phase (Phase 1)

Leukemia, Myelomonocytic, Chronic (Phase 2)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Medulloblastoma (Phase 2)

Melanoma (Phase 2)

Multiple Myeloma (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Myeloproliferative Disorders (Phase 2)

Neoplasm Metastasis (Phase 2)

Neoplasms (Phase 2)

Neoplasms, Germ Cell and Embryonal (Phase 2)

Neuroblastoma (Phase 2)

Ovarian Diseases (Phase 2)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 2)

Pinealoma (Phase 1/Phase 2)

Prostatic Neoplasms (Phase 2)

Rhabdomyosarcoma (Phase 2)

Skin Neoplasms (Phase 2)

Small Cell Lung Carcinoma (Phase 2)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Stomach Neoplasms (Phase 2)

Thyroid Neoplasms (Phase 2)

Tongue Neoplasms (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 45
  • # of Trial Organizations: 36

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue